| 3.27 Data as of May 24 |  -0.04 / -1.21%Today’s Change | 3.10 Today|||52-Week Range 11.76 | -38.88% Year-to-Date |
| Previous close | 3.31 |
| Today’s open | 3.28 |
| Day’s range | 3.25 - 3.31 |
| Volume | 10,368 |
| Average volume (3 months) | 37,992 |
| Market cap | $7.5M |
| Dividend yield | -- |
| Earnings growth (last year) | +46.90% |
| Earnings growth (this year) | +78.10% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 50.52 |
| Price/Book | 1.27 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRMDCorMedix Inc | +0.00 | +0.75% |
| --EnzymeBioSystems | 0.00 | 0.00% |
| --Alternative Energy A... | 0.00 | 0.00% |
| OXBTOxygen Biotherapeuti... | +0.33 | +7.95% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $156.0K |
| Annual profit (last year) | -$8.1M |
| Net profit margin | -5,178.85% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Peter J. Langecker, MD, PhD |
Chief Financial Officer Barbara Riching, CPA |
Corporate headquarters South San Francisco, California |
.
